We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GMP Inspections to Be Risk-Based, CDRH Director Says
GMP Inspections to Be Risk-Based, CDRH Director Says
December 7, 2006
The FDA’s Center for Devices and Radiological Health (CDRH) is taking a new risk-based approach to GMP enforcement.